Anthem Biosciences IPO was fully subscribed on day two of the offer, drawing bids for 73% of the offer a day ago.
The IPO, with a price band of Rs 540 to Rs 570 per share, is a book-building issue of Rs 3,395 crore solely through an offer for sale by promoters and selling shareholders.
As of noon, the IPO had an oversubscribed portion for non-institutional buyers, retail investors, and employees, while institutional investors are yet to participate.
The grey market premium for Anthem Biosciences IPO increased from Rs 116 to Rs 123, suggesting a listing at a 21.6% premium at an estimated price of Rs 693.